Position in EXEL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,298,494
+$362,463 QoQ
Shares Held
23,865
+9.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EP Wealth Advisors, LLC holds $18,108,847 across 26 Biotechnology names. EXEL ranks #4 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,027 | $4,483,981 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
38,135 | $3,108,383 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
6,385 | $1,538,593 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
23,865 | $1,298,494 | |
| 5 | INCY |
Incyte Corp
|
10,863 | $1,231,429 | |
| 6 | BNTX |
BioNTech SE
|
12,723 | $1,183,875 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,301 | $811,225 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
8,761 | $685,723 |
All Filings in EXEL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,298,494 | 23,865 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $936,031 | 21,824 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,002,786 | 22,879 | Shares | Sole | 2026-02-18 | |
| 2025-06-30 | $853,124 | 19,354 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $729,686 | 19,764 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $439,360 | 13,194 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $306,313 | 11,804 | Shares | Sole | 2024-11-15 | |
| No filing history on record for this holder in this stock. | ||||||